Nippon Shinyaku Co., Ltd. (NPPNY)

OTCMKTS · Delayed Price · Currency is USD

6.11

0.00 (0.00%)

Aug 10, 2026, 4:00 PM EST

17.27% (1Y)

Market Cap	1.53B +1.6%
Revenue (ttm)	1.11B +12.2%
Net Income	194.16M +3.4%
EPS	2.88 +3.3%
Shares Out	n/a
PE Ratio	7.86
Forward PE	n/a
Dividend	0.10 (1.60%)
Ex-Dividend Date	Sep 29, 2026

Volume	1
Open	6.11
Previous Close	6.11
Day's Range	6.11 - 6.12
52-Week Range	5.03 - 15.21
Beta	-0.32
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 6, 2026

About Nippon Shinyaku

Nippon Shinyaku Co., Ltd. manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally. The company operates through Pharmaceuticals and Functional Food Business segments. It offers drugs in the fields of urology, hematology, intractable and rare diseases, gynecology, and other diseases; health food ingredients, preservatives, protein preparations, and supplements. The company in the Strategic Partnership with Nippon Shinyaku to develop ATSN-10 that is in Phase I/II of clinical trials for the treatment of GUCY2D-mutant Leb... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1911

Employees 2,309

Stock Exchange OTCMKTS

Ticker Symbol NPPNY

Financial Performance

In fiscal year 2026, Nippon Shinyaku's revenue was 170.77 billion, an increase of 6.58% compared to the previous year's 160.23 billion. Earnings were 29.71 billion, a decrease of -8.76%.

Financial numbers in JPY Financial Statements